COVERAGE
PERSONALIZE YOUR WEBSITE EXPERIENCE
Based on your answer below, content on the site will be optimized to show you the most relevant information first.
Which colorectal cancer (CRC) screening option do you prescribe most often to your average-risk patients?
Your most prescribed CRC screening option:
Eligible patients will get the latest test covered by their insurance to ensure uninterrupted access.
As the Cologuard Plus™ test is available for a longer period, access will expand.
Use the tool below to search your patients’ insurance plans and see which version of the Cologuard test is currently available.
Provider Not Found
Congrats!
Bcbs Iowa Wellmark Msa Medicare Advantage is in network for the Cologuard test.
Have questions about patient access for Cologuard or Cologuard Plus? Contact Customer Care at 1-844-870-8870 for support.
What in-network means
In-network means a health plan has contracted with Exact Sciences Laboratories as part of its preferred lab network. If a patient meets the plan’s clinical criteria, their test may be covered.
Please note that Exact Sciences cannot verify patient's insurance coverage or eligibility.† Coverage and network limitations vary by insurer. To confirm, we recommend the patient contact their insurance provider to understand:
- What the insurer will cover
- Any patient responsibility or out-of-pocket costs
- Any required documentation prior to screening with the Cologuard test
† Some insurers may be considered in-network with Exact Sciences Laboratories, but restrict public use of their name or logo. If you are unsure about a patient's insurer status, please contact the insurer directly.
Most insured patients pay $0 for Cologuard test1*
> 96%
Nationwide, over 96% of all Cologuard patients 45+ have no anticipated out-of-pocket costs1*
Insurance coverage
Eligible patients who are actively enrolled in any state Medicaid program can access the Cologuard test. No payment will be expected from the patient unless the plan requires a co-pay.2†
Follow-up colonoscopy coverage
There is no cost sharing for colonoscopy following a positive Cologuard result. A colonoscopy following a positive Cologuard result is still considered a screening colonoscopy.2,4
January 2022
The federal government issued guidance making it clear that a colonoscopy after a positive noninvasive CRC screening test should be considered part of the screening process.2,4‡
2023 Policy Changes
Positive results from a noninvasive stool-based test, including the Cologuard test, qualify for coverage of follow-up colonoscopy with no cost sharing.2,4‡
As of 2023, Affordable Care Act (ACA) and Centers for Medicare & Medicaid Services (CMS) guidance requires coverage to encourage CRC screening by reducing financial barriers.2,4
Exact Sciences is committed to helping eligible patients access and afford CRC screening
Insurance support:
- Verification of benefits, as requested
- Patient-assisted insurance appeals
Financial support programs:
- Flexible payment plans
- Financial assistance program, based on eligibility
Customer Care:
- Available to providers and patients
- Available at Cologuard.com or by phone at 1-844-870-8870, every day, 6 AM to 10 PM CT
Cologuard ordering
Order the Cologuard test the way that best fits your practice
- Exact Sciences estimate based on historical patient billing as of August 2025. Exceptions for coverage may apply; only your patients’ insurers can confirm how the Cologuard test would be covered.1
- The Cologuard test is a preventive service for NY Medicaid and members have no financial responsibility.2
- For patients with traditional Medicare, a colonoscopy after a positive Cologuard result is still a screening colonoscopy based on updated Centers for Medicare & Medicaid Services regulations, effective January 1, 2023. Medicare does not apply cost sharing to screening colonoscopy. This update does not apply to commercial plans with exempted status.2,4